In-Vitro Diagnostics Global Market Report 2018

1
In-Vitro Diagnostics Global Market Report 2018
Including Point-of-Care Diagnostics
Immunochemistry Diagnostics Clinical Chemistry
Diagnostics Molecular Diagnostics Microbiology
Diagnostics Hemostasis Diagnostics Hematology
Diagnostics Immunohematology Diagnostics Coveri
ng Siemens Healthineers, F. Hoffmann-La Roche
Ltd, Danaher (Beckman Coulter Inc.), Abbott
Laboratories Inc., Thermo Fisher Scientific
Inc. Feb 2018
2
Reasons to Purchase

• Outperform competitors using accurate up to date
  demand-side dynamics information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of
  historic and forecast data and the drivers and
  restraints on the market.
• Create regional and country strategies on the
  basis of local data and analysis.
• Stay abreast of the latest customer and market
  research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future
  developments.
• Utilize the relationships between key data sets
  for superior strategizing.
• Suitable for supporting your internal and
  external presentations with reliable high
  quality data and analysis
• Gain a global perspective on the development of
  the market.
• Report will be updated with the latest data and
  delivered to you within 3-5 working days of
  order.

Scope Markets Covered Point-of-Care Diagnostics
Immunochemistry Clinical Chemistry Molecular
Diagnostics Microbiology Hemostasis
Hematology Immunohematology Companies
Mentioned Siemens Healthineers, F. Hoffmann-La
Roche Ltd, Danaher (Beckman Coulter Inc.),
Abbott Laboratories Inc., Thermo Fisher
Scientific Inc. Countries Brazil, China, France,
Germany, India, Italy, Japan, Spain, Russia, UK,
USA and Australia. Regions Asia-Pacific,
Western Europe, Eastern Europe, North America,
South America, Middle East And Africa Time
series Five years historic and forecast. Data
Ratios of market size and growth to related
markets, GDP, Expenditure Per Capita, The
In-Vitro Diagnostics Market Indicators
Comparison. Data segmentations Country and
regional historic and forecast data, market share
of competitors, market segments. Sourcing and
Referencing Data and analysis throughout the
report is sourced using end notes.
3
In-Vitro Diagnostics Market Characteristics
In-vitro diagnostics (IVD) are used to detect
diseases, infections, and conditions and also
monitor a persons state of health and
therapeutic procedures by examining specimens
derived from the human body such as tissue,
blood, stools, urine and the other body fluids.
Significant technologies incorporated in in-vitro
diagnostics are polymerase chain reaction,
microarray techniques, sequencing technology and
mass spectrometry, which are used for test sample
preparation. In-vitro diagnostic medical devices
include reagents, reagent products, control
materials, calibration materials, kits,
instruments, apparatus, systems, equipment,
pregnancy tests, urine test strips, blood sugar
monitoring systems for diabetics and receptacles
for medical specimens. Based on techniques,
in-vitro diagnostics are classified as
follow Point-of-Care Diagnostics These devices
are designed to aid patients in Immunochemistry
Diagnostics These devices are designed to
diagnose diseases or Clinical Chemistry
Diagnostics Clinical chemistry diagnostics are
used to Molecular Diagnostics Molecular
Diagnostics are used to
4
Hematology Diagnostic Instruments Hematology
diagnostic instruments are Microbiology
Diagnostic Devices Microbiology diagnostic
devices are used to Hemostasis
diagnostics Hemostasis diagnostics are the
devices used to
In this report market value is defined as the
revenues organizations earn by selling their
goods and services within the specified market,
based on the price at which they sell. Only
goods and services traded between entities are
included. The revenues for a specified geography
are consumption values that is, they are
revenues generated by organizations in the
specified geography within the specified market,
irrespective of where they are produced.
5
In-Vitro Diagnostics Market Historic Growth
The global in-vitro diagnostics market grew from
X billion in 2013 to X billion in 2017 at a
compound annual growth rate (CAGR) of X. The
chart and table below shows the year-on-year
growth of the global in-vitro diagnostics market
during 2013 2017.
Drivers of the Market Restraints on the Market
6
In-Vitro Diagnostics Market Forecast Growth
The global in-vitro diagnostics market is
expected to grow from XX billion in 2017 to 68
billion in 2021 at a compound annual growth rate
(CAGR) of XX. The chart and table below shows
the year-on-year growth of the global in-vitro
diagnostics market during 2017 - 2021.
Drivers of the Market Restraints on the Market
7
In-Vitro Diagnostics Market Segmentation
The chart and table below shows the split of the
in-vitro diagnostics market in 2017.
The total market value for in-vitro diagnostics
was X billion in 2017. The markets that are
covered include Point-of-Care Diagnostics
Immunochemistry Diagnostics Clinical Chemistry
Diagnostics Molecular Diagnostics Microbiology
Diagnostic
Devices Hemostasis
Diagnostics Hematology Diagnostic Instruments
Immunohematology Diagnostics Devices Point-of-Care
Diagnostics market was the x largest segment in
the in-vitro diagnostics market with X share of
the market. The market value for the point-of-
care diagnostics market was x billion in 2017.
Immunochemistry Diagnostics made up around X
share of the market. The market value for the
immunochemistry diagnostics was x billion in
2017.
8
In-Vitro Diagnostics Market Regional And Country
Analysis
The Asia Pacific was the x largest region in the
in-vitro diagnostics market in 2017, in-vitro
diagnostics for X billion or X market
share. North America was the x largest region
in-vitro diagnostics for X billion or X market
share. South America was the x largest region
in-vitro diagnostics for X billion or X market
share.
9
In-Vitro Diagnostics Market
Competitive Landscape
The leading competitors in the global in-vitro
diagnostics market are Siemens Healthineers, F.
Hoffmann-La Roche Ltd, Danaher (Beckman Coulter
Inc.), Abbott Laboratories Inc., Thermo Fisher
Scientific Inc. The chart and table below
displays the percentage market share of the top
players in the in-vitro diagnostics market
industry.
Siemens Healthineers generated revenues of XX
billion for the financial year 2017, an XX
increase from the previous year. F. Hoffmann-La
Roche Ltd generated revenues of XX billion for
the financial year 2016, an XX increase from
the previous year. Danaher (Beckman Coulter Inc)
generated revenues of XX billion for the
financial year 2016, an XX increase from the
previous year. Abbott Laboratories Inc. generated
revenues of XX billion for the financial year
2016, an XX increase from the previous year.
10
Thermo Fisher Scientific, Inc. generated revenues
of XX billion for the financial year 2016, an
XX decrease from the previous year. Sysmex
Corporation generated revenues of XX billion for
the financial year 2016, an XX increase from
the previous year. bioMérieux generated revenues
of XX billion for the financial year 2016, an
XX increase from the previous year. Becton
Dickinson Company generated revenues of XX
billion for the financial year 2016, an XX
increase from the previous year. Company Profile
Siemens Healthineers Overview Siemens
Healthineers was the largest company in the
in-vitro diagnostics market in 2017 with a XX
share. It provides medical diagnostics
solutions, healthcare equipment and related
services around the world. Siemens Healthineers
formerly known as Siemens Healthcare operates as
a subsidiary of Siemens AG and is headquartered
in Erlangen, Germany. Products and
Services Siemens Healthineers offers the
following products and services Medical Imaging
products It includes imaging and diagnostic
products Laboratory Diagnostics It consists of
immunoassay, hematology, Healthcare IT
Infrastructure Solutions It provides software
and
11
Strategy Siemens Healthineers growth strategy is
to strengthen its portfolio across the medical
imaging and laboratory diagnostics business while
adding new offerings such as managed services,
consulting and digital services in the growing
market for therapeutic and molecular diagnostics.
In the first quarter of 2016, Financial
Performance Siemens Healthineers generated
revenues of EUR XX billion (XX billion) for the
financial year 2017, a XX increase from the
previous year. Siemens AG had a market F.
Hoffmann-La Roche Ltd Overview Products and
Services Strategy Financial Performance
Danaher (Beckman Coulter Inc.) Overview Products
and Services Strategy Financial
Performance Abbott Laboratories
Inc. Overview Products and Services
Strategy Financial Performance
12
Thermo Fisher Scientific Inc. Overview Products
and Services Strategy Financial Performance